The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Malay Mail on MSN18h
Singapore biotech tycoon Huang Zhenhua’s assets frozen over US$830m suit after misleading Novo Nordisk on ‘new and effective’ hypertension drug, court rulesDanish pharmaceutical giant Novo Nordisk has secured a court order to freeze the worldwide assets of Singapore-based KBP Biosciences and its founder Huang Zhenhua, amid a legal battle over an ...
Novo Nordisk is seeking up to US$830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Novo Nordisk, the Danish pharmaceutical giant, has filed a lawsuit against Singapore-based KBP Biosciences and its founder, ...
Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at ...
Novo Nordisk is seeking up to US$830 million (S$1.1 billion) in damages from KBP Biosciences, according to a ruling by a ...
Pharmaceutical giant Novo Nordisk is seeking as much as US$830 million (S$1.1 billion) in damages in an application to a ...
MT Newswires on MSN2d
European Equities Close Lower in Wednesday Trading; UK Inflation Rises Higher Than ExpectedThe European stock markets closed lower in Wednesday trading as The Stoxx Europe 600 lost 0.95%, Germany's DAX dropped 1.79%, the FTSE 100 in London was down 0.69%, France's CAC 40 fell 1.27%, and the ...
President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they ...
Danish pharma major Novo Nordisk has sued KBP Biosciences and its founder and executive chairman, Huang Zhenhua, for $830 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback